Wolverine Trading
DXCM icon

Wolverine Trading’s DexCom DXCM Stock Holding History

Wolverine Trading’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.9M Buy
193,500
+75,500
+64% +$5.97M 0.01% 800
2025
Q2 		$10.2M Buy
118,000
+24,200
+26% +$1.9M 0.01% 703
2025
Q1 		$6.35M Sell
93,800
-24,400
-21% -$1.99M 0.01% 865
2024
Q4 		$9.22M Sell
118,200
-5,100
-4% -$378K 0.01% 832
2024
Q3 		$8.3M Buy
123,300
+49,200
+66% +$4.04M 0.01% 779
2024
Q2 		$8.4M Sell
74,100
-10,400
-12% -$1.31M 0.01% 715
2024
Q1 		$11.7M Sell
84,500
-13,300
-14% -$1.67M 0.01% 595
2023
Q4 		$12.1M Buy
97,800
+800
+0.8% +$81.7K 0.01% 635
2023
Q3 		$9.05M Buy
97,000
+38,200
+65% +$4.31M 0.01% 667
2023
Q2 		$7.52M Buy
58,800
+9,400
+19% +$1.14M 0.01% 699
2023
Q1 		$5.65M Sell
49,400
-56,300
-53% -$6.3M 0.01% 782
2022
Q4 		$12M Buy
105,700
+2,200
+2% +$242K 0.02% 553
2022
Q3 		$8.5M Buy
103,500
+12,300
+13% +$1.04M 0.01% 626
2022
Q2 		$6.88M Sell
91,200
-43,200
-32% -$3.94M 0.01% 668
2022
Q1 		$17.4M Sell
134,400
-163,600
-55% -$17.9M 0.02% 475
2021
Q4 		$40.3M Sell
298,000
-31,600
-10% -$4.54M 0.05% 275
2021
Q3 		$45M Buy
329,600
+81,600
+33% +$10.3M 0.05% 256
2021
Q2 		$26.5M Buy
248,000
+10,400
+4% +$999K 0.04% 328
2021
Q1 		$20.6M Sell
237,600
-110,800
-32% -$10.4M 0.03% 386
2020
Q4 		$31.6M Buy
348,400
+155,600
+81% +$13.9M 0.05% 262
2020
Q3 		$19.4M Buy
192,800
+12,400
+7% +$1.3M 0.05% 317
2020
Q2 		$18M Sell
180,400
-4,800
-3% -$429K 0.05% 280
2020
Q1 		$12.9M Sell
185,200
-228,400
-55% -$14.2M 0.04% 349
2019
Q4 		$22.4M Buy
+413,600
New +$19.6M 0.05% 327
2019
Q3 		– Sell
-226,800
Closed -$8.5M – 4472
2019
Q2 		$8.5M Sell
226,800
-18,400
-8% -$578K 0.02% 605
2019
Q1 		$7.3M Buy
245,200
+148,400
+153% +$5.21M 0.02% 658
2018
Q4 		$2.86M Sell
96,800
-72,400
-43% -$2.3M 0.01% 1158
2018
Q3 		$6.05M Buy
169,200
+79,600
+89% +$2.47M 0.01% 852
2018
Q2 		$1.66M Hold
89,600
– – ﹤0.01% 1763
2018
Q1 		$1.66M Buy
89,600
+9,600
+12% +$142K ﹤0.01% 1763
2017
Q4 		$1.15M Sell
80,000
-25,600
-24% -$333K ﹤0.01% 2065
2017
Q3 		$1.29M Buy
105,600
+52,400
+98% +$926K ﹤0.01% 1670
2017
Q2 		$974K Buy
+53,200
New +$983K ﹤0.01% 1762
2017
Q1 		– Sell
-91,600
Closed -$1.37M – 4413
2016
Q4 		$1.37M Buy
91,600
+45,200
+97% +$801K 0.01% 1645
2016
Q3 		$1.02M Sell
46,400
-35,200
-43% -$783K ﹤0.01% 1837
2016
Q2 		$1.61M Buy
+81,600
New +$1.39M 0.01% 1256

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wolverine Trading's DXCM Position: Q3 2025 in Review

Wolverine Trading increased its DexCom (DXCM) stake by 165% in Q3 2025, buying an estimated $4.1M and bringing the position to 83,167 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Wolverine Trading first reported a position in DXCM in Q4 2016 and has held it in 28 quarters since. The position peaked at $30.6M in Q3 2021. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Wolverine Trading held 83,167 shares of DexCom worth $5.53M as of Q3 2025.
  • Wolverine Trading bought 51,783 DexCom shares in Q3 2025, an estimated $4.1M.
  • DexCom made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1321 holding.
  • Wolverine Trading first reported a position in DexCom in Q4 2016 and has held it in 28 quarters since.
  • Wolverine Trading's DexCom position peaked at $30.6M in Q3 2021.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.